{"id":"https://openalex.org/W4388076848","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0541","title":"541 Diabetes and glucose level as metabolic determinants of immune checkpoint inhibitors response in melanoma","display_name":"541 Diabetes and glucose level as metabolic determinants of immune checkpoint inhibitors response in melanoma","publication_year":2023,"publication_date":"2023-10-31","ids":{"openalex":"https://openalex.org/W4388076848","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0541"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2023-sitc2023.0541","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0541","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.0541","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/A615.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/A615.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063047715","display_name":"Yu Jen Jan","orcid":"https://orcid.org/0000-0002-2962-2933","observed_orcids":["https://orcid.org/0000-0002-2962-2933"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yu Jen A Jan","raw_affiliation_strings":["Harvard Medical School, Boston, MA, USA","Massachusetts General Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079622150","display_name":"Soravis Alm Osataphan","orcid":"https://orcid.org/0000-0002-6503-4418","observed_orcids":["https://orcid.org/0000-0002-6503-4418"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Soravis Osataphan","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Boston, MA, USA","Harvard Medical School, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Boston, MA, USA","institution_ids":["https://openalex.org/I1316535847"]},{"raw_affiliation_string":"Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007502940","display_name":"Cho\u2010Han Chiang","orcid":"https://orcid.org/0000-0002-5757-6161","observed_orcids":["https://orcid.org/0000-0002-5757-6161"]},"institutions":[{"id":"https://openalex.org/I1297058315","display_name":"Mount Auburn Hospital","ror":"https://ror.org/00nhpk003","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1297058315"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cho Han Chiang","raw_affiliation_strings":["Harvard Medical School, Boston, MA, USA","Mount Auburn Hospital, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Mount Auburn Hospital, Cambridge, MA, USA","institution_ids":["https://openalex.org/I1297058315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035343389","display_name":"Kerry Lynn Reynolds","orcid":"https://orcid.org/0000-0002-7793-654X","observed_orcids":["https://orcid.org/0000-0002-7793-654X"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kerry Reynolds","raw_affiliation_strings":["Harvard Medical School, Boston, MA, USA","Massachusetts General Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5008479799","display_name":"Ryan Joseph Sullivan","orcid":"https://orcid.org/0000-0001-5344-6645","observed_orcids":["https://orcid.org/0000-0001-5344-6645"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan Sullivan","raw_affiliation_strings":["Harvard Medical School, Boston, MA, USA","Massachusetts General Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I4210087915"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A615","last_page":"A615"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12433","display_name":"Skin Diseases and Diabetes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9789999723434448},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":1.0},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9929999709129333},{"id":"https://openalex.org/keywords/hyperlipidemia","display_name":"hyperlipidemia","score":0.8960000276565552},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.8690000176429749},{"id":"https://openalex.org/keywords/blood-glucose","display_name":"blood glucose","score":0.5580000281333923},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.5550000071525574},{"id":"https://openalex.org/keywords/body-mass-index","display_name":"body mass index","score":0.9290000200271606},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.878000020980835},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9079999923706055},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":0.9950000047683716},{"id":"https://openalex.org/keywords/atezolizumab","display_name":"atezolizumab","score":0.9900000095367432},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.718999981880188},{"id":"https://openalex.org/keywords/real-world-data","display_name":"real-world data","score":0.6690000295639038},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.5879999995231628},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-related-pneumonitis","display_name":"immune-related pneumonitis","score":0.5350000262260437}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8963969349861145},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.8913265466690063},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.8250152468681335},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.7563716173171997},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6359919905662537},{"id":"https://openalex.org/C2775949291","wikidata":"https://www.wikidata.org/wiki/Q20707748","display_name":"Atezolizumab","level":5,"score":0.6344665288925171},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5626689195632935},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.518501877784729},{"id":"https://openalex.org/C2780586474","wikidata":"https://www.wikidata.org/wiki/Q332428","display_name":"Overweight","level":3,"score":0.41924458742141724},{"id":"https://openalex.org/C2780221984","wikidata":"https://www.wikidata.org/wiki/Q131191","display_name":"Body mass index","level":2,"score":0.40191611647605896},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.38535118103027344},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2283574342727661},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.09056740999221802}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2023-sitc2023.0541","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0541","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.0541","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/A615.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:c92660ebd96547c28858113d354d5121","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/c92660ebd96547c28858113d354d5121","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2023-sitc2023.0541","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0541","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.0541","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/A615.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4388076848.pdf","grobid_xml":"https://content.openalex.org/works/W4388076848.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4404136736","https://openalex.org/W4410816416","https://openalex.org/W4297831625","https://openalex.org/W4414850811","https://openalex.org/W7117306984","https://openalex.org/W4400272416","https://openalex.org/W4410803157","https://openalex.org/W2947093659","https://openalex.org/W4412436914","https://openalex.org/W4362522815"],"abstract_inverted_index":{"Background":[0],"The":[1,215,400],"current":[2],"guideline-recommended":[3],"treatment":[4,61,278,343],"for":[5,244,288,317],"melanoma":[6,68,83,159],"at":[7,130,226],"stage":[8],"IIb":[9],"or":[10,297,356],"above":[11],"involves":[12],"immune":[13,36],"checkpoint":[14],"inhibitors":[15],"(ICIs).":[16],"Recent":[17],"studies":[18,370],"have":[19],"explored":[20],"the":[21,27,45,55,93,97,131,187,194,227,252,268,375],"correlations":[22],"between":[23,104],"metabolic":[24,58],"derangements":[25],"and":[26,38,113,119,125,147,180,182,206,246,290,319,337,387,389],"efficacy":[28],"of":[29,57,133,155,189,193,208,222,229,254],"ICIs,":[30],"considering":[31],"their":[32],"impact":[33],"on":[34,60,213],"T-cell-mediated":[35],"response":[37],"interactions":[39],"with":[40,82,85,143,158,161,235,272,301,346,351,360,385,396],"other":[41,367],"immunologic":[42],"compartments":[43],"in":[44,80,96,260,349,366,383,392],"tumor":[46],"micro-environments.":[47],"In":[48],"this":[49],"study,":[50],"we":[51],"aim":[52],"to":[53,107,305,373],"investigate":[54],"effect":[56],"abnormalities":[59],"outcomes":[62,382,391],"by":[63,117,404],"analyzing":[64],"real-world":[65],"data":[66,124],"from":[67],"patients":[69,81,157,195,209,271,350,384,394],"receiving":[70],"ICIs.":[71,397],"Methods":[72],"We":[73],"performed":[74],"a":[75,220],"retrospective":[76],"multicenter":[77],"cohort":[78],"study":[79,216,401],"treated":[84,160,395],"ICIs":[86,162],"including":[87],"pembrolizumab,":[88,170],"nivolumab,":[89,173],"ipilimumab,":[90,176],"atezolizumab":[91],"across":[92],"ten":[94],"hospitals":[95],"Mass":[98,405],"General":[99,406],"Brigham":[100,407],"health":[101],"care":[102],"system":[103],"January":[105],"2014":[106],"December":[108],"2022.":[109],"Type":[110],"2":[111],"diabetes":[112,225,336,386],"hyperlipidemia":[114],"were":[115,137,163,204,210],"defined":[116],"ICD-9":[118],"10":[120],"diagnostic":[121],"codes.":[122],"Laboratory":[123],"body":[126],"mass":[127],"index":[128],"(BMI)":[129],"time":[132,228],"starting":[134,230],"ICI":[135,190,231,342],"therapy":[136,232],"collected.":[138],"Overall":[139],"survival":[140,145,238,282,303,348],"was":[141,233,299,364,402],"evaluated":[142],"Kaplan-Meier":[144],"analysis":[146],"cox":[148],"proportional":[149],"hazards":[150],"model.":[151],"Results":[152],"A":[153],"total":[154],"2082":[156],"included.":[164],"Among":[165],"all":[166],"patients,":[167],"43%":[168],"received":[169,172,175,178,184],"16%":[171],"9.4%":[174],"30.5%":[177],"ipilimumab":[179],"nivolumab":[181],"0.9%":[183],"atezolizumab.":[185],"At":[186],"start":[188],"therapy,":[191],"13.3%":[192],"had":[196,201,279],"type":[197,223,334],"II":[198,224,335],"diabetes,":[199],"36.8%":[200],"hyperlipidemia,":[202],"34.8%":[203],"overweight":[205,296,355],"33.1%":[207],"obese":[211,298,357],"based":[212],"BMI.":[214],"found":[217],"that":[218,333,379],"having":[219],"diagnosis":[221],"associated":[234,300,345,359],"worse":[236,280,347,381],"overall":[237,261,281],"(Unadjusted":[239,283,308],"HR:1.32,":[240],"95%CI:1.09\u20131.61,":[241],"p=0.005;":[242],"Adjusted":[243,287,316],"age":[245,289,318],"sex-":[247,291,320],"HR:1.24,":[248],"95%CI:1.02\u20131.51,":[249],"p=0.03).":[250],"However,":[251,353],"presence":[253],"dyslipidemia":[255],"showed":[256],"no":[257],"significant":[258],"difference":[259],"survival.":[262],"When":[263],"using":[264],"126":[265,275],"mg/dL":[266,276],"as":[267,363,412],"glucose":[269,273,339],"cutoff,":[270],"\u2265":[274],"pre-ICI":[277],"HR:1.64,":[284],"95%CI:1.41\u20131.91,":[285],"p<0.001;":[286],"HR:1.52,":[292],"95%CI:1.30\u20131.78,":[293],"p<0.001).":[294],"Being":[295],"better":[302,361,390],"compared":[304],"normal":[306],"BMI":[307],"HR:0.71,":[309,321],"95%CI:0.60\u20130.84,":[310],"p<0.001,":[311,323],"HR:0.67,":[312],"95%CI:0.56\u20130.79,":[313],"p<0.001":[314,326],"respectively;":[315],"95%CI:0.60\u20130.85,":[322],"HR:0.70,":[324],"95%CI:0.59\u20130.83,":[325],"respectively).":[327],"Conclusions":[328],"Overall,":[329],"these":[330],"findings":[331],"indicate":[332],"higher":[338],"levels":[340],"before":[341],"are":[344,371],"melanoma.":[352],"being":[354],"is":[358],"survival,":[362],"observed":[365],"studies.":[368],"Further":[369],"needed":[372],"explore":[374],"underlying":[376],"molecular":[377],"mechanisms":[378],"drive":[380],"hyperglycemia":[388],"overweight/obese":[393],"Ethics":[398],"Approval":[399],"approved":[403],"IRB":[408],"Protocol":[409],"#:":[410],"2023P000244":[411],"an":[413],"exempt":[414],"study.":[415]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2023-11-01T00:00:00"}